APP and Alzheimer disease: Attempting to identify the specific culprit for increased seizure susceptibility in the APP cascade by using genetic mouse models of AD is notoriously difficult, since inhibiting the production of one breakdown product results in the accumulation of peptides of other processing pathways that might also impact neuronal activity.